nodes	percent_of_prediction	percent_of_DWPC	metapath
Equilin—SHBG—obesity	0.802	1	CbGaD
Equilin—HSD17B1—endocrine gland—obesity	0.00413	0.368	CbGeAlD
Equilin—SHBG—hindbrain—obesity	0.00217	0.193	CbGeAlD
Equilin—Estradiol—FABP2—obesity	0.00116	0.118	CrCbGaD
Equilin—SHBG—cardiovascular system—obesity	0.00102	0.0903	CbGeAlD
Equilin—SHBG—pituitary gland—obesity	0.0009	0.08	CbGeAlD
Equilin—SHBG—adipose tissue—obesity	0.000896	0.0797	CbGeAlD
Equilin—SHBG—adrenal gland—obesity	0.000804	0.0714	CbGeAlD
Equilin—SHBG—endocrine gland—obesity	0.000697	0.062	CbGeAlD
Equilin—Estriol—ESR2—obesity	0.000685	0.0697	CrCbGaD
Equilin—SHBG—liver—obesity	0.000628	0.0559	CbGeAlD
Equilin—Estriol—SHBG—obesity	0.000625	0.0636	CrCbGaD
Equilin—Ethinyl Estradiol—NR1I2—obesity	0.000594	0.0605	CrCbGaD
Equilin—Estropipate—ESR2—obesity	0.000524	0.0533	CrCbGaD
Equilin—Estropipate—SHBG—obesity	0.000478	0.0486	CrCbGaD
Equilin—Estropipate—SLC22A1—obesity	0.000472	0.048	CrCbGaD
Equilin—Estriol—ESR1—obesity	0.000422	0.0429	CrCbGaD
Equilin—Estradiol—NR1I2—obesity	0.000392	0.0399	CrCbGaD
Equilin—Ethinyl Estradiol—ESR2—obesity	0.000374	0.0381	CrCbGaD
Equilin—Conjugated Estrogens—COMT—obesity	0.000351	0.0357	CrCbGaD
Equilin—Ethinyl Estradiol—SHBG—obesity	0.000341	0.0347	CrCbGaD
Equilin—Conjugated Estrogens—ESR2—obesity	0.000327	0.0333	CrCbGaD
Equilin—Estrone—ESR2—obesity	0.000326	0.0332	CrCbGaD
Equilin—Estropipate—ESR1—obesity	0.000323	0.0328	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—PRLHR—obesity	0.000314	0.00177	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GH1—obesity	0.000314	0.00177	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PPARD—obesity	0.000313	0.00176	CbGpPWpGaD
Equilin—HSD17B1—Disease—ACP5—obesity	0.000311	0.00176	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC27A1—obesity	0.000306	0.00173	CbGpPWpGaD
Equilin—HSD17B1—Disease—G6PD—obesity	0.000303	0.00171	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GLUL—obesity	0.0003	0.0017	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—FABP4—obesity	0.0003	0.0017	CbGpPWpGaD
Equilin—HSD17B1—Disease—HK1—obesity	0.000299	0.00169	CbGpPWpGaD
Equilin—Estrone—SHBG—obesity	0.000297	0.0302	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—APLN—obesity	0.000295	0.00167	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PYY—obesity	0.000295	0.00167	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	0.00029	0.00163	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—UCP3—obesity	0.000285	0.00161	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ECHS1—obesity	0.000285	0.00161	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HSD11B1—obesity	0.000285	0.00161	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—UCP2—obesity	0.000285	0.00161	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ADH1B—obesity	0.00028	0.00158	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PNLIP—obesity	0.00028	0.00158	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—APOB—obesity	0.000276	0.00156	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GPAM—obesity	0.000276	0.00156	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ACSL1—obesity	0.000276	0.00156	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PPARGC1B—obesity	0.000276	0.00156	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SDC3—obesity	0.000273	0.00154	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PCK1—obesity	0.000268	0.00151	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HADH—obesity	0.000268	0.00151	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—FADS1—obesity	0.000268	0.00151	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HCRT—obesity	0.000267	0.00151	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PMCH—obesity	0.000267	0.00151	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NPY5R—obesity	0.000267	0.00151	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NMU—obesity	0.000267	0.00151	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—LPL—obesity	0.000264	0.00149	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ACP5—obesity	0.00026	0.00147	CbGpPWpGaD
Equilin—HSD17B1—Disease—RBP4—obesity	0.000258	0.00145	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—GPX1—obesity	0.000257	0.00145	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NPY1R—obesity	0.000256	0.00145	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MC4R—obesity	0.000256	0.00145	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MC3R—obesity	0.000256	0.00145	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NPY2R—obesity	0.000256	0.00145	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—G6PD—obesity	0.000254	0.00143	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PPY—obesity	0.000251	0.00142	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HK1—obesity	0.000251	0.00142	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SREBF2—obesity	0.000251	0.00142	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CD36—obesity	0.00025	0.00141	CbGpPWpGaD
Equilin—Estradiol—ESR2—obesity	0.000247	0.0251	CrCbGaD
Equilin—HSD17B1—Signaling Pathways—HDAC8—obesity	0.000247	0.00139	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GIP—obesity	0.000247	0.00139	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRKCH—obesity	0.000247	0.00139	CbGpPWpGaD
Equilin—HSD17B1—Disease—PRKAR2B—obesity	0.000244	0.00138	CbGpPWpGaD
Equilin—HSD17B1—Disease—CST3—obesity	0.000244	0.00138	CbGpPWpGaD
Equilin—HSD17B1—Disease—DCN—obesity	0.000242	0.00137	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—LPA—obesity	0.000242	0.00137	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—LPIN1—obesity	0.000237	0.00134	CbGpPWpGaD
Equilin—HSD17B1—Disease—NCF2—obesity	0.000236	0.00133	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LEPR—obesity	0.000234	0.00132	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PPARA—obesity	0.000233	0.00131	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOA5—obesity	0.000232	0.00131	CbGpPWpGaD
Equilin—HSD17B1—Disease—NAMPT—obesity	0.000231	0.0013	CbGpPWpGaD
Equilin—Ethinyl Estradiol—ESR1—obesity	0.000231	0.0235	CrCbGaD
Equilin—HSD17B1—Disease—GCK—obesity	0.00023	0.0013	CbGpPWpGaD
Equilin—HSD17B1—Disease—APOC3—obesity	0.000228	0.00129	CbGpPWpGaD
Equilin—HSD17B1—Disease—IAPP—obesity	0.000228	0.00129	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—AGT—obesity	0.000226	0.00127	CbGpPWpGaD
Equilin—Estradiol—SHBG—obesity	0.000225	0.0229	CrCbGaD
Equilin—Estradiol—SLC22A1—obesity	0.000222	0.0226	CrCbGaD
Equilin—HSD17B1—Metabolism—CLOCK—obesity	0.000221	0.00125	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC22A1—obesity	0.000221	0.00125	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—APOE—obesity	0.000221	0.00125	CbGpPWpGaD
Equilin—HSD17B1—Disease—SDC1—obesity	0.000219	0.00124	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—CAV1—obesity	0.000219	0.00124	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—APOA1—obesity	0.000218	0.00123	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GLP1R—obesity	0.000216	0.00122	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SULT2A1—obesity	0.000216	0.00122	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKR1C3—obesity	0.000216	0.00122	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—DPYD—obesity	0.000212	0.0012	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADRB3—obesity	0.00021	0.00118	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GAL—obesity	0.000205	0.00116	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PRKAR2B—obesity	0.000204	0.00115	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—DCN—obesity	0.000203	0.00115	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—C5AR1—obesity	0.000203	0.00114	CbGpPWpGaD
Equilin—Conjugated Estrogens—ESR1—obesity	0.000201	0.0205	CrCbGaD
Equilin—Estrone—ESR1—obesity	0.000201	0.0204	CrCbGaD
Equilin—HSD17B1—Disease—GOT2—obesity	0.0002	0.00113	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CG—obesity	0.000199	0.00113	CbGpPWpGaD
Equilin—Estradiol—AR—obesity	0.000198	0.0201	CrCbGaD
Equilin—HSD17B1—Metabolism—CPT1A—obesity	0.000197	0.00111	CbGpPWpGaD
Equilin—HSD17B1—Disease—FASN—obesity	0.000196	0.00111	CbGpPWpGaD
Equilin—HSD17B1—Disease—PARP1—obesity	0.000195	0.0011	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NAMPT—obesity	0.000194	0.00109	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PPARG—obesity	0.000192	0.00109	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—LIPC—obesity	0.000192	0.00109	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GCK—obesity	0.000192	0.00109	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOC3—obesity	0.000191	0.00108	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—POMC—obesity	0.00019	0.00107	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CETP—obesity	0.000186	0.00105	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRKG1—obesity	0.000185	0.00105	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCK—obesity	0.000185	0.00105	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOS1—obesity	0.000184	0.00104	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SDC1—obesity	0.000184	0.00104	CbGpPWpGaD
Equilin—HSD17B1—Disease—TCF7L2—obesity	0.000182	0.00103	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKR1C3—obesity	0.000181	0.00102	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RBP4—obesity	0.00018	0.00102	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GLP1R—obesity	0.00018	0.00102	CbGpPWpGaD
Equilin—HSD17B1—Disease—SLC2A4—obesity	0.000179	0.00101	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SCARB1—obesity	0.000178	0.001	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HRH3—obesity	0.000178	0.001	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCKAR—obesity	0.000178	0.001	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CD—obesity	0.000175	0.000989	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—ALB—obesity	0.000173	0.000977	CbGpPWpGaD
Equilin—HSD17B1—Disease—GOT1—obesity	0.000173	0.000976	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SREBF1—obesity	0.000173	0.000974	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRKAR2B—obesity	0.000171	0.000965	CbGpPWpGaD
Equilin—HSD17B1—Disease—PRL—obesity	0.00017	0.000962	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GOT2—obesity	0.000168	0.000947	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3R1—obesity	0.000166	0.000934	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NCF2—obesity	0.000165	0.000932	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—FASN—obesity	0.000164	0.000927	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—BCHE—obesity	0.000164	0.000923	CbGpPWpGaD
Equilin—Estrone—CYP2E1—obesity	0.000163	0.0166	CrCbGaD
Equilin—HSD17B1—Disease—FOXO3—obesity	0.000162	0.000915	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NPY—obesity	0.000161	0.000908	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APOC3—obesity	0.00016	0.000902	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IAPP—obesity	0.00016	0.000902	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP2E1—obesity	0.000158	0.000891	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NQO1—obesity	0.000156	0.000881	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HTR1B—obesity	0.000155	0.000876	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CRH—obesity	0.000155	0.000876	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SDC1—obesity	0.000153	0.000866	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CB—obesity	0.000153	0.000862	CbGpPWpGaD
Equilin—Estradiol—ESR1—obesity	0.000152	0.0155	CrCbGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PTGS2—obesity	0.000151	0.000854	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKR1C3—obesity	0.000151	0.000852	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—SLC2A4—obesity	0.00015	0.000844	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GCG—obesity	0.00015	0.000844	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYCS—obesity	0.000148	0.000833	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NPS—obesity	0.000147	0.00083	CbGpPWpGaD
Equilin—HSD17B1—Disease—APOB—obesity	0.000147	0.000829	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GGT1—obesity	0.000145	0.000818	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GOT1—obesity	0.000145	0.000818	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HTR2C—obesity	0.000144	0.000814	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—DRD1—obesity	0.000144	0.000814	CbGpPWpGaD
Equilin—Estropipate—ALB—obesity	0.000144	0.0146	CrCbGaD
Equilin—HSD17B1—Metabolism—NCOA1—obesity	0.000143	0.000805	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—STK11—obesity	0.000141	0.000794	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CYP19A1—obesity	0.000141	0.000794	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NTRK2—obesity	0.00014	0.000792	CbGpPWpGaD
Equilin—HSD17B1—Disease—LPL—obesity	0.00014	0.000791	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADRB1—obesity	0.00014	0.000789	CbGpPWpGaD
Equilin—HSD17B1—Disease—FOXO1—obesity	0.000139	0.000785	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PARP1—obesity	0.000137	0.000772	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GHRL—obesity	0.000137	0.000772	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—DRD4—obesity	0.000136	0.000766	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—COMT—obesity	0.000131	0.000738	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CNR1—obesity	0.00013	0.000731	CbGpPWpGaD
Equilin—HSD17B1—Disease—PRKCD—obesity	0.000129	0.000729	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PPARGC1A—obesity	0.000129	0.000728	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GNB3—obesity	0.000129	0.000728	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—HMOX1—obesity	0.000128	0.000724	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TCF7L2—obesity	0.000127	0.000718	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—DRD2—obesity	0.000126	0.000713	CbGpPWpGaD
Equilin—HSD17B1—Disease—MTHFR—obesity	0.000126	0.000712	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GNAS—obesity	0.000126	0.000709	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PTPN1—obesity	0.000125	0.000706	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GCG—obesity	0.000125	0.000706	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOB—obesity	0.000123	0.000694	CbGpPWpGaD
Equilin—HSD17B1—Disease—IRS2—obesity	0.00012	0.000678	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRL—obesity	0.000119	0.000674	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—STK11—obesity	0.000118	0.000664	CbGpPWpGaD
Equilin—HSD17B1—Disease—APOE—obesity	0.000118	0.000663	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—LPL—obesity	0.000117	0.000663	CbGpPWpGaD
Equilin—HSD17B1—Disease—CAV1—obesity	0.000116	0.000657	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PLG—obesity	0.000116	0.000656	CbGpPWpGaD
Equilin—HSD17B1—Disease—APOA1—obesity	0.000116	0.000656	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—GPX1—obesity	0.000115	0.000646	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FOXO3—obesity	0.000114	0.000641	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ADRB2—obesity	0.000113	0.000639	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CD36—obesity	0.000112	0.00063	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SOCS1—obesity	0.000112	0.000629	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SOCS3—obesity	0.00011	0.000622	CbGpPWpGaD
Equilin—HSD17B1—Disease—BAD—obesity	0.00011	0.000618	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GNB3—obesity	0.000108	0.000608	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IGF2—obesity	0.000106	0.000598	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—MTHFR—obesity	0.000106	0.000597	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—GNAS—obesity	0.000105	0.000592	CbGpPWpGaD
Equilin—HSD17B1—Disease—IRS1—obesity	0.000105	0.000592	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PPARA—obesity	0.000104	0.000585	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APOB—obesity	0.000103	0.00058	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AGT—obesity	0.0001	0.000567	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCL5—obesity	0.0001	0.000567	CbGpPWpGaD
Equilin—HSD17B1—Disease—INS—obesity	0.0001	0.000567	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOE—obesity	9.84e-05	0.000555	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LPL—obesity	9.82e-05	0.000554	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—CAV1—obesity	9.75e-05	0.00055	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—FOXO1—obesity	9.75e-05	0.00055	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RPS6KB1—obesity	9.73e-05	0.000549	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—APOA1—obesity	9.73e-05	0.000549	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT2—obesity	9.7e-05	0.000548	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CD—obesity	9.32e-05	0.000526	CbGpPWpGaD
Equilin—HSD17B1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	9.32e-05	0.000526	CbGpPWpGaD
Equilin—HSD17B1—Disease—SERPINE1—obesity	9.22e-05	0.00052	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRKCD—obesity	9.04e-05	0.00051	CbGpPWpGaD
Equilin—HSD17B1—Disease—TYK2—obesity	8.97e-05	0.000506	CbGpPWpGaD
Equilin—Estrone—ALB—obesity	8.94e-05	0.0091	CrCbGaD
Equilin—HSD17B1—Disease—RHOA—obesity	8.9e-05	0.000502	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CG—obesity	8.88e-05	0.000501	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—HTR2A—obesity	8.85e-05	0.000499	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—C3—obesity	8.84e-05	0.000499	CbGpPWpGaD
Equilin—HSD17B1—Disease—NOS3—obesity	8.8e-05	0.000497	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3R1—obesity	8.8e-05	0.000497	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PPARG—obesity	8.57e-05	0.000484	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—POMC—obesity	8.45e-05	0.000477	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IRS2—obesity	8.41e-05	0.000475	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—INS—obesity	8.41e-05	0.000474	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AGT—obesity	8.4e-05	0.000474	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—LEP—obesity	8.23e-05	0.000464	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APOE—obesity	8.23e-05	0.000464	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CAV1—obesity	8.15e-05	0.00046	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—APOA1—obesity	8.13e-05	0.000459	CbGpPWpGaD
Equilin—HSD17B1—Disease—MTOR—obesity	8.13e-05	0.000459	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CB—obesity	8.13e-05	0.000459	CbGpPWpGaD
Equilin—HSD17B1—Disease—PTGS2—obesity	8.05e-05	0.000454	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—ESR1—obesity	7.86e-05	0.000443	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CD—obesity	7.81e-05	0.000441	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PRKCB—obesity	7.76e-05	0.000438	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—F2—obesity	7.76e-05	0.000438	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—ALB—obesity	7.71e-05	0.000435	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—BAD—obesity	7.67e-05	0.000433	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CG—obesity	7.43e-05	0.000419	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3R1—obesity	7.37e-05	0.000416	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—NOS3—obesity	7.37e-05	0.000416	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IRS1—obesity	7.34e-05	0.000414	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—POMC—obesity	7.07e-05	0.000399	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—INS—obesity	7.03e-05	0.000397	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—CCL2—obesity	6.92e-05	0.00039	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CB—obesity	6.81e-05	0.000384	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IGF1—obesity	6.8e-05	0.000384	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKT2—obesity	6.79e-05	0.000383	CbGpPWpGaD
Equilin—Estradiol—ALB—obesity	6.78e-05	0.00689	CrCbGaD
Equilin—HSD17B1—Metabolism—PTGS2—obesity	6.74e-05	0.000381	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CD—obesity	6.53e-05	0.000368	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—SERPINE1—obesity	6.46e-05	0.000364	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TYK2—obesity	6.28e-05	0.000354	CbGpPWpGaD
Equilin—HSD17B1—Disease—STAT3—obesity	6.28e-05	0.000354	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—RHOA—obesity	6.23e-05	0.000352	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3R1—obesity	6.16e-05	0.000348	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—NOS3—obesity	6.16e-05	0.000348	CbGpPWpGaD
Equilin—HSD17B1—Disease—MYC—obesity	5.84e-05	0.000329	CbGpPWpGaD
Equilin—HSD17B1—Disease—TGFB1—obesity	5.82e-05	0.000329	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MTOR—obesity	5.69e-05	0.000321	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CB—obesity	5.69e-05	0.000321	CbGpPWpGaD
Equilin—HSD17B1—Disease—PIK3CA—obesity	4.95e-05	0.00028	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MMP9—obesity	4.95e-05	0.000279	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MAPK8—obesity	4.81e-05	0.000271	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—STAT3—obesity	4.4e-05	0.000248	CbGpPWpGaD
Equilin—HSD17B1—Disease—IL6—obesity	4.39e-05	0.000248	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—PIK3CA—obesity	4.15e-05	0.000234	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—MYC—obesity	4.09e-05	0.000231	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—TGFB1—obesity	4.08e-05	0.00023	CbGpPWpGaD
Equilin—HSD17B1—Disease—AKT1—obesity	4.05e-05	0.000228	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—PIK3CA—obesity	3.47e-05	0.000196	CbGpPWpGaD
Equilin—HSD17B1—Metabolism—AKT1—obesity	3.39e-05	0.000191	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—IL6—obesity	3.07e-05	0.000173	CbGpPWpGaD
Equilin—HSD17B1—Signaling Pathways—AKT1—obesity	2.83e-05	0.00016	CbGpPWpGaD
